
GBC CLIA Detecting Technology
Chemiluminescent Immunoassay (CLIA) is an advanced diagnostic technology that detects the concentration of antigens or antibodies in blood and other bodily fluids using chemiluminescent reactions. When target molecules bind with specific reagents, light is emitted, which is then captured and quantified by high-performance analyzers.
Compared to traditional testing methods, CLIA offers superior sensitivity, specificity, and automation, making it ideal for high-throughput clinical testing. It is widely applied in:
- Thyroid function testing
- Tumor marker detection
- Infectious disease screening
- Comprehensive hormonal analysis
SYSTEMS
GBC CL i120 CLIA System
The GBC CL i120 is an advanced chemiluminescence immunoassay analyzer designed for high-sensitivity protein and antibody detection. Featuring a fully automated workflow, intuitive software, and robust throughput, it is optimized for tumor markers, hormonal profiles, and infectious disease screening.

LET’S CONNECT
Discover how GBC’s experts can support your next complex diagnostic project
